Acyl-CoA:Diacylglycerol Acyltransferase: A Key Player in the Regulation of Fatty Acid and Glucose Metabolism in Mammalian Systems

References (84)

1. 1 Triglyceride accumulation protects against fatty acid-induced lipotoxicity [DOI]
2. 2 Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1 H NMR spectroscopy study [DOI]
3. 3 Thematic Review Series: Glycerolipids. DGAT enzymes and triacylglycerol biosynthesis [DOI]
4. 4 Identification of a gene encoding an acyl CoA:diacylglycerol acyltransferase, a key enzyme in triacylglycerol synthesis [DOI]
5. 5 Obesity resistance and multiple mechanisms of triglyceride synthesis in mice lacking Dgat [DOI]
6. 6 Cloning of DGAT2, a Second Mammalian Diacylglycerol Acyltransferase, and Related Family Members [DOI]
7. 7 Lipopenia and Skin Barrier Abnormalities in DGAT2-deficient Mice [DOI]
8. 8 Skeletal Muscle Lipid Content and Oxidative Enzyme Activity in Relation to Muscle Fiber Type in Type 2 Diabetes and Obesity [DOI]
9. 9 Muscle fiber type is associated with obesity and weight loss [DOI]
10. 10 Gluttony, sloth and the metabolic syndrome: a roadmap to lipotoxicity [DOI]
11. 11 Acute exercise increases triglyceride synthesis in skeletal muscle and prevents fatty acid–induced insulin resistance [DOI]
12. 12 DGAT2 Is a New Diacylglycerol Acyltransferase Gene Family [DOI]
13. 13 Skeletal muscle glycolytic and oxidative enzyme capacities are determinants of insulin sensitivity and muscle composition in obese women [DOI]
14. 14 Increased insulin and leptin sensitivity in mice lacking acyl CoA:diacylglycerol acyltransferase 1 [DOI]
15. 15 Free Fatty Acids Inhibit Insulin Signaling–Stimulated Endothelial Nitric Oxide Synthase Activation Through Upregulating PTEN or Inhibiting Akt Kinase [DOI]
16. 16 Fat content in individual muscle fibers of lean and obese subjects [DOI]
17. 17 Evolutionary view of acyl-CoA diacylglycerol acyltransferase (DGAT), a key enzyme in neutral lipid biosynthesis [DOI]
18. 18 Free fatty acids and skeletal muscle insulin resistance [DOI]
19. 19 Targeting Acyl-CoA:Diacylglycerol Acyltransferase 1 (DGAT1) with Small Molecule Inhibitors for the Treatment of Metabolic Diseases [DOI]
20. 20 AMP-activated protein kinase and coordination of hepatic fatty acid metabolism of starved/carbohydrate-refed rats [DOI]
21. 21 Validation of Diacyl Glycerolacyltransferase I as a Novel Target for the Treatment of Obesity and Dyslipidemia Using a Potent and Selective Small Molecule Inhibitor [DOI]
22. 22 A Murine Model of Isolated Cardiac Steatosis Leads to Cardiomyopathy [DOI]
23. 23 DGAT1 inhibitors as anti-obesity and anti-diabetic agents.
24. 24 Intramuscular triglyceride and muscle insulin sensitivity: Evidence for a relationship in nondiabetic subjects [DOI]
25. 25 Recent insights into stearoyl-CoA desaturase-1 [DOI]
26. 26 The Physiology of Cellular Liporegulation [DOI]
27. 27 Increased Efficiency of Fatty Acid Uptake Contributes to Lipid Accumulation in Skeletal Muscle of High Fat-Fed Insulin-Resistant Rats [DOI]
28. 28 Stearoyl-CoA desaturase-2 gene expression is required for lipid synthesis during early skin and liver development [DOI]
29. 29 Concerted elevation of acyl-coenzyme A:diacylglycerol acyltransferase (DGAT) activity through independent stimulation of mRNA expression of DGAT1 and DGAT2 by carbohydrate and insulin [DOI]
30. 30 Lack of stearoyl-CoA desaturase 1 upregulates basal thermogenesis but causes hypothermia in a cold environment [DOI]
31. 31 Morphometric documentation of abnormal intramyocellular fat storage and reduced glycogen in obese patients with Type II diabetes [DOI]
32. 32 Obesity resistance of the stearoyl-CoA desaturase-deficient (scd1 -/-) mouse results from disruption of the epidermal lipid barrier and adaptive thermoregulation [DOI]
33. 33 Obesity as a clinical and public health problem: Is there a need for a new definition based on lipotoxicity effects? [DOI]
34. 34 Proof of mechanism for the DGAT1 inhibitor AZD7687 : results from a first‐time‐in‐human single‐dose study [DOI]
35. 35 A novel diacylglycerol acyltransferase (DGAT2) is decreased in human psoriatic skin and increased in diabetic mice [DOI]
36. 36 Whole-body Insulin Resistance in the Absence of Obesity in FVB Mice With Overexpression of Dgat1 in Adipose Tissue [DOI]
37. 37 Diet‐Induced Changes in Stearoyl‐CoA Desaturase 1 Expression in Obesity‐Prone and ‐Resistant Mice [DOI]
38. 38 Analysis of energy expenditure at different ambient temperatures in mice lacking DGAT1 [DOI]
39. 39 DGAT1 overexpression in muscle by in vivo DNA electroporation increases intramyocellular lipid content [DOI]
40. 40 DGAT inhibitors for obesity.
41. 41 Deficiency of Acyl Coenzyme A:Diacylglycerol Acyltransferase 1 Increases Leptin Sensitivity in Murine Obesity Models [DOI]
42. 42 Regulation of triacylglycerol synthesis in the liver a decrease in diacylglycerol acyltransferase activity after treatment of isolated rat hepatocytes with glucagon [DOI]
43. 43 Effects of DGAT1 deficiency on energy and glucose metabolism are independent of adiponectin [DOI]
44. 44 Glycogen of high molecular weight from mammalian muscle [DOI]
45. 45 Properties of phosphatidate phosphohydrolase and diacylglycerol acyltransferase activities in the isolated rat heart. Effect of glucagon, ischaemia and diabetes [DOI]
46. 46 Reversible ATP‐dependent inactivation of adipose diacylglycerol acyltransferase [DOI]
47. 47 Synthesis and secretion of very low density lipoproteins by isolated rat hepatocytes in suspension: Role of diacylglycerol acyltransferase [DOI]
48. 48 A decrease in diacylglycerol acyltransferase after treatment of rat adipocytes with adrenaline [DOI]
49. 49 LIPID DEFICIENCIES, LEUKOCYTOSIS, BRITTLE SKIN—A LETHAL SYNDROME CAUSED BY A RECESSIVE MUTATION, EDEMATOUS (OED), IN THE MOUSE [DOI]
50. 50 Fight fat with DGAT [DOI]
51. 51 Skeletal Muscle Triglyceride Levels Are Inversely Related to Insulin Action [DOI]
52. 52 Loss of stearoyl–CoA desaturase-1 function protects mice against adiposity [DOI]
53. 53 Altered glycolytic and oxidative capacities of skeletal muscle contribute to insulin resistance in NIDDM [DOI]
54. 54 Ectopic Fat Depots and Cardiovascular Disease [DOI]
55. 55 M USCLE T RIGLYCERIDE AND I NSULIN R ESISTANCE [DOI]
56. 56 Upregulation of myocellular DGAT1 augments triglyceride synthesis in skeletal muscle and protects against fat-induced insulin resistance [DOI]
57. 57 DGAT enzymes are required for triacylglycerol synthesis and lipid droplets in adipocytes [DOI]
58. 58 Skeletal muscle lipid deposition and insulin resistance: effect of dietary fatty acids and exercise [DOI]
59. 59 Skeletal muscle fiber composition is related to adiposity and in vitro glucose transport rate in humans [DOI]
60. 60 Increased insulin and leptin sensitivity in mice lacking acyl CoA:diacylglycerol acyltransferase 1 [DOI]
61. 61 DGAT1 Expression Increases Heart Triglyceride Content but Ameliorates Lipotoxicity [DOI]
62. 62 Intramyocellular Lipids: Anthropometric Determinants and Relationships with Maximal Aerobic Capacity and Insulin Sensitivity [DOI]
63. 63 Skeletal muscle triglyceride levels are inversely related to insulin action [DOI]
64. 64 Inhibition of Triglyceride Synthesis as a Treatment Strategy for Obesity [DOI]
65. 65 Protein Kinase C Function in Muscle, Liver, and β-Cells and Its Therapeutic Implications for Type 2 Diabetes [DOI]
66. 66 Ectopic fat and cardiovascular disease: What is the link? [DOI]
67. 67 The Effect of Exercise and Nutrition on Intramuscular Fat Metabolism and Insulin Sensitivity [DOI]
68. 68 Heterogeneity of insulin action in individual muscles in vivo: euglycemic clamp studies in rats [DOI]
69. 69 Intramyocellular lipids form an important substrate source during moderate intensity exercise in endurance‐trained males in a fasted state [DOI]
70. 70 Dissociation of Obesity and Impaired Glucose Disposal in Mice Overexpressing Acyl Coenzyme A:Diacylglycerol Acyltransferase 1 in White Adipose Tissue [DOI]
71. 71 Insulin resistance and elevated triglyceride in muscle: more important for survival than ‘thrifty’ genes? [DOI]
72. 72 Ectopic fat accumulation: an important cause of insulin resistance in humans.
73. 73 Increased lipid accumulation and insulin resistance in transgenic mice expressing DGAT2 in glycolytic (type II) muscle [DOI]
74. 74 Obesity resistance and enhanced glucose metabolismin mice transplanted with white adipose tissue lackingacyl CoA:diacylglycerol acyltransferase 1 [DOI]
75. 75 DGAT1 deficiency decreases PPAR expression and does not lead to lipotoxicity in cardiac and skeletal muscle [DOI]
76. 76 Paradoxical Coupling of Triglyceride Synthesis and Fatty Acid Oxidation in Skeletal Muscle Overexpressing DGAT1 [DOI]
77. 77 Expression of DGAT2 in White Adipose Tissue Is Regulated by Central Leptin Action [DOI]
78. 78 Role of Adipocyte-Derived Factors in Enhancing Insulin Signaling in Skeletal Muscle and White Adipose Tissue of Mice Lacking Acyl CoA:Diacylglycerol Acyltransferase 1 [DOI]
79. 79 Endurance training-induced accumulation of muscle triglycerides is coupled to upregulation of stearoyl-CoA desaturase 1 [DOI]
80. 80 Role of stearoyl-CoA desaturase-1 in skeletal muscle function and metabolism [DOI]
81. 81 Development of insulin resistance in the JCR:LA-cp rat: role of triacylglycerols and effects of MEDICA 16. [DOI]
82. 82 Variability of triacylglycerol content in human skeletal muscle biopsy samples [DOI]
83. 83 Influence of Fatty Acids on Microsomal Diacylglycerol Acyltransferase Activity in Primary Cultures of Hepatocytes [DOI]
84. 84 Deficiency of Acyl Coenzyme A:Diacylglycerol Acyltransferase 1 Increases Leptin Sensitivity in Murine Obesity Models [DOI]

Cited by 2

Related research

• Assessing Non-Alcoholic Fatty Liver Disease and Associated Liver Enzyme Levels in Persons with Type II Diabetes Mellitus — shares topic coverage
• Unmasking Sarcopenic Obesity in Chronic Hepatitis: A Cross-Sectional Study of Body Composition and Pro-Inflammatory Diets in Lomé, Togo — shares topic coverage
• Diet-Induced Fatty Hepatic Steatosis in Male Spontaneously Diabetic Torii (SDT) Fatty Rats, A Genetic Model for Obese Type 2 Diabetes — shares topic coverage
• Curcumin Effects on Hepatic Steatosis and Histopathology in an Obese Mouse Mode — shares topic coverage
• Assessment of Hepatic Steatosis and Fibrosis in Egyptian Patients with Type 2 Diabetes Mellitus — shares topic coverage